EXITEN
Main information
- Trade name:
- EXITEN 10 TAB
- Active ingredient:
- Fluoxetine Hcl.
- Available from:
- Synokem
- Dosage:
- 20 MG
- Pharmaceutical form:
- TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
24-7-2018
Veterinary medicine European public assessment report (EPAR): Reconcile, fluoxetine, Revision: 8, Authorised
Europe - EMA - European Medicines Agency
19-6-2018
Opinion/decision on a Paediatric investigation plan (PIP): -, (RS)-Bacoflen / Naltrexone HCl / D-Sorbitol (PXT3003), Therapeutic area: Neurology
Europe - EFSA - European Food Safety Authority EFSA Journal
16-7-2018
Reconcile (Nexcyon Pharmaceuticals Ltd)
Reconcile (Active substance: Fluoxetine) - Centralised - Renewal - Commission Decision (2018)4770 of Mon, 16 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/133/R-18
Europe -DG Health and Food Safety